| Announce Date | 02/10/2026 |
| EPS Normalized Actual | $0.43 (Beat by $0.17) |
| EPS GAAP Actual | $0.43 (Beat by $0.17) |
| Revenue Actual | $0.070023B |
| Revenue Surprise | Beat by $70.023M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.083008 |
| EPS GAAP Estimate | $0.083008 |
| Revenue Estimate | $0.073350373B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 1.1 | 10.14 | 1.06869 | 1.12888 | 1 |
| Dec 2027 | 0.8675 | 12.85 | 0.71 | 1.09 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0873 | 0.0673 | 0.070023B | 18.42% | 1.99M |
| FQ2 2025 (Jun 2025) | -0.65 | -0.591667 | 0.06846B | 100% | 3.93M |
| FQ3 2024 (Sep 2024) | -0.0627 | -1.60411 | 0.057127B | 100% | 57.13M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.069812B | 100% | 69.81M |
| FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 0.064512B | 100% | 64.51M |
| FQ2 2024 (Jun 2024) | -0.0772 | -1.41979 | 0B | NAN% | 0M |
| FQ1 2021 (Mar 2021) | -0.0005 | -0.0005 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.11 | -1.68645 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.083008
Consensus Revenue Estimates
0.073350373B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.42 | -- | 0.41748 | 0.42203 | 1 |
| FQ3 2026 (Sep 2026) | 0.256 | 65.9 | 0.256 | 0.256 | 1 |
| FQ2 2026 (Jun 2026) | 0.148 | 539.19 | 0.148 | 0.148 | 1 |
| FQ1 2026 (Mar 2026) | 0.083008 | 160.24 | 0.08251032 | 0.08340916 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.1B | -- | 0.1B | 0.1B | 2 |
| FQ3 2026 (Sep 2026) | 0.08B | 15.17 | 0.08B | 0.08B | 4 |
| FQ2 2026 (Jun 2026) | 0.08B | 13.11 | 0.08B | 0.08B | 5 |
| FQ1 2026 (Mar 2026) | 0.07B | 12.05 | 0.07B | 0.07B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
0
Revenue # of in-lines
3
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.02 | 0.0873 | 0.0673 | 77.09% |
| FQ2 2025 (Jun 2025) | -0.058333 | -0.65 | -0.591667 | 91.03% |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.0627 | -1.60411 | 2558.39% |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 100% | |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.0772 | -1.41979 | 1839.11% |
| FQ1 2021 (Mar 2021) | -0.0005 | -0.0005 | 100% | |
| FQ1 2024 (Mar 2024) | 1.57645 | -0.11 | -1.68645 | 1533.14% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.07B | $0.07B | $1.99M | 2.84% |
| FQ2 2025 (Jun 2025) | $0.06B | $0.07B | $3.93M | 5.74% |
| FQ3 2024 (Sep 2024) | $0B | $0.06B | $57.13M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.07B | $69.81M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.06B | $64.51M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |